EUVIMEDEUVIMED entdecken
Crossref

Roflumilast ameliorates ovariectomy-induced depressive-like behavior in rats via activation of AMPK/mTOR/ULK1-dependent autophagy pathway

Eman S Zaki, Rabab H Sayed, Muhammed A Saad, Muhammed F El-Yamany

Life Sciences · 2023-08 · 327 · 121806

DOI: 10.1016/j.lfs.2023.121806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2023-08. Verfasst von Eman S Zaki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Ovariectomy, Phosphodiesterase 4 Inhibitors, Depression. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Faculty of Veterinary Medicine, Damanhour University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Roflumilast, a well-known phosphodiesterase-4 (PDE-4) inhibitor, possess an anti-inflammatory activity with approved indications in chronic obstructive pulmonary disease. This study aimed to evaluate the neuroprotective role of roflumilast in ovariectomy (OVX)-induced depressive-like behavior in female rats and to shed light on a potential autophagy enhancing effect. MAIN METHODS: Rats were randomly divided into four groups: sham, OVX, OVX + roflumilast (1 mg/kg, p.o), and OVX + roflumilast + chloroquine (CQ) (50 mg/kg, i.p). Drugs were administered for 4 weeks starting 2 weeks after OVX. KEY FINDINGS: Roflumilast improved the depressive-like behaviors observed in OVX rats as evidenced by decreasing both forced swimming and open field immobility times while, increasing % sucrose preference and number of open field crossed squares. Histopathological analysis provides further evidence of roflumilast's beneficial effects, demonstrating that roflumilast ameliorated the neuronal damage caused by OVX. Roflumilast antidepressant potential was mediated via restoring hippocampal cAMP and BDNF levels as well as down-regulating PDE4 expression. Moreover, roflumilast revealed anti-inflammatory and anti-apoptotic effects via hindering TNF-α level and diminishing Bax/Bcl2 ratio. Roflumilast restored the autophagic function via up-regulation of p-AMPK, p-ULK1, Beclin-1 and LC3II/I expression, along with downregulation of P62 level and p-mTOR protein expression. The autophagy inhibitor CQ was used to demonstrate the suggested pathway. SIGNIFICANCE: The present study revealed that roflumilast showed an anti-depressant activity in OVX female rats via turning on AMPK/mTOR/ULK1-dependent autophagy pathway; and neurotrophic, anti-inflammatory, and anti-apoptotic activities. Roflumilast could offer a more secure alternative to hormone replacement therapy for postmenopausal depression treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesOvariectomyPhosphodiesterase 4 InhibitorsDepressionAnimalsFemaleRatsAutophagyAutophagy-Related Protein-1 HomologIntracellular Signaling Peptides and ProteinsTOR Serine-Threonine KinasesAminopyridinesBenzamidesCyclopropanes

Stichwörter der Autor:innen

ApoptosisAutophagyInflammationPDE4 inhibitionPostmenopausal depressionRoflumilast

Substanzen

AMP-Activated Protein KinasesAutophagy-Related Protein-1 HomologIntracellular Signaling Peptides and ProteinsPhosphodiesterase 4 InhibitorsTOR Serine-Threonine KinasesmTOR protein, ratRoflumilastAminopyridinesBenzamidesCyclopropanes

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt; Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman, 4184, United Arab Emirates. Ele…

Förderung

  • Faculty of Veterinary Medicine, Damanhour University

Zitieren

APA

Zaki, E. S., Sayed, R. H., Saad, M. A., & El-Yamany, M. F. (2023). Roflumilast ameliorates ovariectomy-induced depressive-like behavior in rats via activation of AMPK/mTOR/ULK1-dependent autophagy pathway. Life Sciences, 327, 121806. https://doi.org/10.1016/j.lfs.2023.121806

Vancouver

Zaki ES, Sayed RH, Saad MA, El-Yamany MF. Roflumilast ameliorates ovariectomy-induced depressive-like behavior in rats via activation of AMPK/mTOR/ULK1-dependent autophagy pathway. Life Sciences. 2023;327:121806. doi:10.1016/j.lfs.2023.121806

BibTeX
@article{Zaki2023,
  author = {Zaki, Eman S and Sayed, Rabab H and Saad, Muhammed A and El-Yamany, Muhammed F},
  title = {Roflumilast ameliorates ovariectomy-induced depressive-like behavior in rats via activation of AMPK/mTOR/ULK1-dependent autophagy pathway},
  journal = {Life Sciences},
  year = {2023},
  volume = {327},
  pages = {121806},
  doi = {10.1016/j.lfs.2023.121806}
}
Kostenlos starten →